The Asia Pacific Artificial Intelligence in Diagnostics Market is expected to witness market growth of 22.4% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Other Diagnosis Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $39.4 million by 2031. The Japan market is registering a CAGR of 24.3% during 2024-2031. Additionally, the India market is expected to showcase a CAGR of 26.1% during 2024-2031.
Governments and regulatory bodies support AI adoption in healthcare by approving AI-driven diagnostic tools and establishing guidelines for their safe use. AI-driven diagnostics are integrated with EHRs to improve data accessibility, streamline workflows, and enhance clinical decision-making. AI enables remote diagnostics, allowing healthcare providers to reach patients in rural and underserved areas. AI-powered diagnostic apps and wearable devices facilitate virtual consultations and remote monitoring.
Moreover, the use of AI in diagnostics extends beyond disease detection, encompassing a wide range of applications that enhance healthcare delivery. AI automates the analysis of medical images, reducing human error and improving diagnostic accuracy. AI models predict disease risks based on patient history, lifestyle, and genetic data, enabling early intervention and preventive care. AI-driven diagnostics support precision medicine by tailoring treatment plans based on a patient’s unique characteristics.
In India, the hospital sector was valued at INR 7.94 trillion in FY21 and is expected to more than double by FY27, reaching INR 18.34 trillion. The diagnostics sector, currently worth $4 billion, is also evolving rapidly, with organized players holding 25% of the market. The growing healthcare infrastructure, rising investments, and increasing adoption of AI-driven laboratory and radiology solutions are key drivers. AI-powered diagnostics will enhance efficiency in imaging, automate pathology processes, and support precision medicine, catering to India’s large and diverse patient population. The expansion of the organized diagnostics sector will further facilitate the integration of AI technologies to improve accuracy, reduce turnaround time, and support remote diagnostics in rural areas.
The China market dominated the Asia Pacific Other Diagnosis Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $39.4 million by 2031. The Japan market is registering a CAGR of 24.3% during 2024-2031. Additionally, the India market is expected to showcase a CAGR of 26.1% during 2024-2031.
Governments and regulatory bodies support AI adoption in healthcare by approving AI-driven diagnostic tools and establishing guidelines for their safe use. AI-driven diagnostics are integrated with EHRs to improve data accessibility, streamline workflows, and enhance clinical decision-making. AI enables remote diagnostics, allowing healthcare providers to reach patients in rural and underserved areas. AI-powered diagnostic apps and wearable devices facilitate virtual consultations and remote monitoring.
Moreover, the use of AI in diagnostics extends beyond disease detection, encompassing a wide range of applications that enhance healthcare delivery. AI automates the analysis of medical images, reducing human error and improving diagnostic accuracy. AI models predict disease risks based on patient history, lifestyle, and genetic data, enabling early intervention and preventive care. AI-driven diagnostics support precision medicine by tailoring treatment plans based on a patient’s unique characteristics.
In India, the hospital sector was valued at INR 7.94 trillion in FY21 and is expected to more than double by FY27, reaching INR 18.34 trillion. The diagnostics sector, currently worth $4 billion, is also evolving rapidly, with organized players holding 25% of the market. The growing healthcare infrastructure, rising investments, and increasing adoption of AI-driven laboratory and radiology solutions are key drivers. AI-powered diagnostics will enhance efficiency in imaging, automate pathology processes, and support precision medicine, catering to India’s large and diverse patient population. The expansion of the organized diagnostics sector will further facilitate the integration of AI technologies to improve accuracy, reduce turnaround time, and support remote diagnostics in rural areas.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Market Report Segmentation
By Component
- Software
- Hardware
- Services
By Diagnosis
- Neurology
- Radiology
- Chest & Lung
- Oncology
- Cardiology
- Pathology
- Other Diagnosis
By Country
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Artificial Intelligence in Diagnostics Market by Component
Chapter 6. Asia Pacific Artificial Intelligence in Diagnostics Market by Diagnosis
Chapter 7. Asia Pacific Artificial Intelligence in Diagnostics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Methodology
LOADING...
